DISEASE INDICATIONS: HIV/AIDS

MANUFACTURER: ViiV Healthcare

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Vocabria (cabotegravir) is a medication used to treat and prevent HIV-1 infection. It belongs to a class of drugs called integrase strand transfer inhibitors that block the virus from replicating, reducing the amount of HIV in the body.